HER 2/neu as a theranostic marker in colorectal carcinoma and its relationship with histopathological correlates-A pilot study

Journal Title: Indian Journal of Pathology and Oncology - Year 2017, Vol 4, Issue 3

Abstract

Introduction: Colorectal carcinoma(CRC) is one among the many leading causes of cancer related mortality worldwide. The survival rate of patients with CRC is better because of advancements made in the treatment modalities, in terms of surgery and chemotherapeutic options. This study is done to know the immunoexpression of Her 2/neu in CRC and its correlation with histologic grades. Her 2/ neu is considered to be a beneficial Immunohistochemical (IHC) marker for colon cancer which can be used for predicting the prognosis and for targeted therapeutic modality. Materials and Method: The present pilot study was done to understand the expression of Her 2 /neu in histologically proven 25 cases of adenocarcinoma colon using monoclonal anti Her 2 /neu antibody (Biogenix). Positivity was recorded as per the consensus panel recommendations on Her 2/neu scoring.(1) The clinical profile of the patients were obtained from the archives in the Pathology department of our institution. Results: This study had a total of 25 hemicolectomy specimens of colorectal carcinoma. Of the total 25 cases, 14 cases (56%) were males and 11 cases (44%) were females. Forty percentage of patients were in the age group of 50-60 years. Histopathologically, most of them were adenocarcinomas. Her 2/neu expression was negative in all the 25 cases of colorectal carcinoma in our study. The control tissue was Her 2 /neu positive breast carcinoma with complete membrane staining in the tumor cells(3+). Conclusions: Her 2/neu is considered as a therapeutic modality in advanced and metastatic CRC cases. This was a pilot study and we need to perform the IHC stain on more cases to understand its expression in our population.

Authors and Affiliations

G. Priyanka, Leena Dennis Joseph, Monica Kumbhat

Keywords

Related Articles

Cytological correlation of spectrum of head and neck lesions with epidemiological and diagnostic parameters

Background: Fine Needle Aspiration Cytology (FNAC) has many advantages and utilities in cervical region. Most of the studies documented in the literature regarding head and neck masses, either describe spectrum of lesion...

Histopathological spectrum of thyroid lesions

Introduction Thyroid lesions are fairly common amp have a wide spectrum of diseases ranging from functional immune mediated to neoplastic lesionsObjectives 1 To study the occurrence of various lesions of the thyroidnbsp2...

Study of paediatric renal biopsies with clinicopathologic correlation and comparison with literature on adult renal biopsies

Introduction Renal biopsy is frequently used in complete workup for renal diseases The kidney reacts in a limited number of patterns to various injuries and the clinical manifestations corresponding to these reactions ar...

Editorial

I am pleased to present before you the October – December 2017 issue of IJPO. The journal has risen to great height in the past few years. A large numbers of research articles are being submitted for publication. This is...

Haematological profile in typhoid fever

1. To determine haematological changes in typhoid fever. 2. To establish early diagnosis using haematological parameters for prompt treatment of the disease. Materials and Method: This study was conducted...

Download PDF file
  • EP ID EP315585
  • DOI 10.18231/2394-6792.2017.0096
  • Views 45
  • Downloads 0

How To Cite

G. Priyanka, Leena Dennis Joseph, Monica Kumbhat (2017). HER 2/neu as a theranostic marker in colorectal carcinoma and its relationship with histopathological correlates-A pilot study. Indian Journal of Pathology and Oncology, 4(3), 446-449. https://europub.co.uk/articles/-A-315585